Hippocampus-targeted BDNF gene therapy to rescue cognitive impairments of Alzheimer's disease in multiple mouse models.

During the water maze test, the treated APP/PS1 mice performed better, while rTg4510 mice showed a trend toward improved learning ability during training, although this improvement did not reach statistical significance, which might be caused by significant neuronal loss and hippocampal atrophy in rTg4510 mice at early adulthood, with BDNF administration could only partially improve spatial memory.

also in 53,322 other papers